Clinical Trials for Ependymoma, Anaplastic

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT ID: NCT04541082

This clinical trial is investigating a new medication called ONC206, taken by mouth, for patients with certain types of brain tumors that have come back after treatment. The main goal of the study ...